Antileishmanial activity of HIV protease inhibitors.

  title={Antileishmanial activity of HIV protease inhibitors.},
  author={Dianella Savoia and Tiziano Allice and P. Tovo},
  journal={International journal of antimicrobial agents},
  volume={26 1},
The proteasomes of some protozoa are possible targets for chemotherapy. Leishmaniasis is a major health problem in human immunodeficiency virus (HIV) co-infected subjects. Two HIV protease inhibitors (PI), indinavir and saquinavir, have been shown to block proteasome functions; we therefore investigated their effects on the growth of two Leishmania spp. (Leishmania major and Leishmania infantum). After 24 h of treatment, both drugs exhibited a dose-dependent antileishmanial activity, with 50… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 33 extracted citations


Publications referenced by this paper.
Showing 1-10 of 21 references

Incidence and factors for symptomatic visceral leishmaniasis among human im odeficiency virus type 1-infected patients from Spain in the of highly active antiretroviral therapy

  • R De La Rosa, JA Pineda, J Delgado
  • J Clin Microbiol
  • 2002
2 Excerpts

Similar Papers

Loading similar papers…